Hu Yuanyuan, Zou Sen, Wang Zheng, Liu Ying, Ren Li, Hao Yanling, Sun Shasha, Hu Xintao, Ruan Yuhua, Ma Liying, Shao Yiming, Hong Kunxue
State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Vaccines (Basel). 2021 Mar 25;9(4):311. doi: 10.3390/vaccines9040311.
We sought to analyze the evolutionary characteristics and neutralization sensitivity of viruses in a human immunodeficiency virus type 1 (HIV-1) subtype B' infected plasma donor with broadly neutralizing activity, which may provide information for new broadly neutralizing antibodies (bNAbs) isolation and immunogen design. A total of 83 full-length envelope genes were obtained by single-genome amplification (SGA) from the patient's plasma at three consecutive time points (2005, 2006, and 2008) spanning four years. In addition, 28 Env-pseudotyped viruses were constructed and their neutralization sensitivity to autologous plasma and several representative bNAbs were measured. Phylogenetic analysis showed that these env sequences formed two evolutionary clusters (Cluster I and II). Cluster I viruses vanished in 2006 and then appeared as recombinants two years later. In Cluster II viruses, the V1 length and N-glycosylation sites increased over the four years of the study period. Most viruses were sensitive to concurrent and subsequent autologous plasma, and to bNAbs, including 10E8, PGT121, VRC01, and 12A21, but all viruses were resistant to PGT135. Overall, 90% of Cluster I viruses were resistant to 2G12, while 94% of Cluster II viruses were sensitive to 2G12. We confirmed that HIV-1 continued to evolve even in the presence of bNAbs, and two virus clusters in this donor adopted different escape mechanisms under the same humoral immune pressure.
我们试图分析一名具有广泛中和活性的人类免疫缺陷病毒1型(HIV-1)B'亚型感染血浆供体中病毒的进化特征和中和敏感性,这可能为新型广泛中和抗体(bNAbs)的分离和免疫原设计提供信息。通过单基因组扩增(SGA),在跨越四年的三个连续时间点(2005年、2006年和2008年)从患者血浆中总共获得了83个全长包膜基因。此外,构建了28种Env假型病毒,并测量了它们对自体血浆和几种代表性bNAbs的中和敏感性。系统发育分析表明,这些env序列形成了两个进化簇(簇I和簇II)。簇I病毒在2006年消失,两年后作为重组体出现。在簇II病毒中,在研究的四年期间,V1长度和N-糖基化位点增加。大多数病毒对同时期和后续的自体血浆以及bNAbs敏感,包括10E8、PGT121、VRC01和12A21,但所有病毒对PGT135耐药。总体而言,90%的簇I病毒对2G12耐药,而94%的簇II病毒对2G12敏感。我们证实,即使在存在bNAbs的情况下,HIV-1仍在继续进化,并且该供体中的两个病毒簇在相同的体液免疫压力下采用了不同的逃逸机制。